UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Next-Generation Antibody Therapeutics: Discovery, Development and Beyond: highlights of the third annual conference of the Chinese Antibody Society

Zhang, H; Deng, M; Pei, F; Wang, S; Ho, M; (2019) Next-Generation Antibody Therapeutics: Discovery, Development and Beyond: highlights of the third annual conference of the Chinese Antibody Society. Antibody Therapeutics , 2 (4) pp. 99-107. 10.1093/abt/tbz012. Green open access

[thumbnail of tbz012.pdf]
Preview
Text
tbz012.pdf - Published Version

Download (1MB) | Preview

Abstract

The Chinese Antibody Society (CAS) convened the third annual conference in Cambridge, Massachusetts, USA on April 7, 2019. More than 600 global members attended the meeting. The theme of this conference was Next-Generation Antibody Therapeutics: Discovery, Development and Beyond. The meeting covered a vast variety of topics including cancer immunotherapy, single-domain antibodies as well as bispecific antibodies, immunotoxins, transgenic mouse platforms for next-generation monoclonal antibody discovery and antibody chemistry, manufacturing and controls (CMCs). Two hot topics were comprehensively discussed by the prestigious panelists and hosts at the panel discussions during the conferences, i.e., bispecific antibodies and antibody CMC.

Type: Article
Title: Next-Generation Antibody Therapeutics: Discovery, Development and Beyond: highlights of the third annual conference of the Chinese Antibody Society
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/abt/tbz012
Publisher version: http://dx.doi.org/10.1093/abt/tbz012
Language: English
Additional information: © The Author(s) 2019. Published by Oxford University Press on behalf of Antibody Therapeutics. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: Chinese Antibody Society, antibody therapeutics, bispecific antibodies, chemistry manufacturing and Controls (CMC), immuno-oncology, immunotoxin, single-domain antibody, transgenic mouse platforms
UCL classification: UCL
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Biochemical Engineering
URI: https://discovery.ucl.ac.uk/id/eprint/10127751
Downloads since deposit
51Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item